Vender R - Search Results

1

Clinical Goals and Barriers to Effective Psoriasis Care.

Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB. Strober BE, et al. Among authors: vender r. Dermatol Ther (Heidelb). 2019 Mar;9(1):5-18. doi: 10.1007/s13555-018-0279-5. Epub 2018 Dec 21. Dermatol Ther (Heidelb). 2019. PMID: 30578464 Free PMC article.

2

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial.

Leonardi C, Langley RG, Papp K, Tyring SK, Wasel N, Vender R, Unnebrink K, Gupta SR, Valdecantos WC, Bagel J. Leonardi C, et al. Among authors: vender r. Arch Dermatol. 2011 Apr;147(4):429-36. doi: 10.1001/archdermatol.2010.384. Epub 2010 Dec 20. Arch Dermatol. 2011. PMID: 21173304 Clinical Trial.

3

Canadian guidelines for the management of plaque psoriasis: overview.

Papp K, Gulliver W, Lynde C, Poulin Y, Ashkenas J; Canadian Psoriasis Guidelines Committee. Papp K, et al. J Cutan Med Surg. 2011 Jul-Aug;15(4):210-9. doi: 10.2310/7750.2011.10066. J Cutan Med Surg. 2011. PMID: 21781627

4

Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations.

Albrecht L, Bourcier M, Ashkenas J, Papp K, Shear N, Toole J, Vender R, Wasel N; Canadian Psoriasis Guidelines Committee. Albrecht L, et al. Among authors: vender r. J Cutan Med Surg. 2011 Nov-Dec;15(6):309-21. doi: 10.2310/7750.2011.10080. J Cutan Med Surg. 2011. PMID: 22202506 Review.

5

Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting.

Vender R, Lynde C, Ho V, Chau D, Poulin-Costello M. Vender R, et al. Appl Health Econ Health Policy. 2012 Sep 1;10(5):343-53. doi: 10.1007/BF03261868. Appl Health Econ Health Policy. 2012. PMID: 22877226

6

Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice.

Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M. Vender R, et al. J Cutan Med Surg. 2012 Nov-Dec;16(6):407-16. doi: 10.1177/120347541201600609. J Cutan Med Surg. 2012. PMID: 23149196 Clinical Trial.

7

One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian population.

Vender R, Lynde C, Gilbert M, Ho V, Sapra S, Poulin-Costello M. Vender R, et al. J Cutan Med Surg. 2013 Mar-Apr;17(2):129-38. doi: 10.2310/7750.2012.12036. J Cutan Med Surg. 2013. PMID: 23582167 Clinical Trial.

8

Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus.

Bhatia N, Lynde C, Vender R, Bourcier M. Bhatia N, et al. Among authors: vender r. J Cutan Med Surg. 2013 Dec;17 Suppl 2:S47-54. J Cutan Med Surg. 2013. PMID: 24388558 Review.

9

Clinical features of external genital warts.

Lynde C, Vender R, Bourcier M, Bhatia N. Lynde C, et al. Among authors: vender r. J Cutan Med Surg. 2013 Dec;17 Suppl 2:S55-60. J Cutan Med Surg. 2013. PMID: 24388559 Review.

10

Therapeutic options for external genital warts.

Vender R, Bourcier M, Bhatia N, Lynde C. Vender R, et al. J Cutan Med Surg. 2013 Dec;17 Suppl 2:S61-7. J Cutan Med Surg. 2013. PMID: 24388560 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page